Latest News about JNJ
Recent news which mentions JNJ
Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
July 23, 2024
From Benzinga
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
July 22, 2024
From Benzinga
From Benzinga
From Benzinga
This Hidden Gem Vanguard ETF Is Chock-Full of Magnificent Stocks. Here's Why It's a Buy Now.
July 21, 2024
From Motley Fool
From InvestorPlace
3 Blue-Chip Stocks to Buy for Christmas in July
July 19, 2024
From InvestorPlace
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
July 18, 2024
From Benzinga
3 Dividend Stocks That Demand Investor Attention
July 18, 2024
From InvestorPlace
From Benzinga
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
July 18, 2024
From Benzinga
3 Blue-Chip Stocks to Buy If the Dow Crashes
July 18, 2024
From InvestorPlace
From Benzinga
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Johnson & Johnson's Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&A Costs
July 17, 2024
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Dow Jones Closes At Record High As Traders Turn Bullish Amid Hopes Of Fed Cutting Rates In September
July 17, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.